The level of the EGR1 protein in prostate cancer tissue positively correlates with the Gleason score, which predicts the tumor proliferation ability, and negatively correlates with the differentiation degree of prostate cancer cells (32). This evidence concerns the gene EGR1 and prostate cancer.